Offer systemic therapy as first-line defense


Buenos Aires — In selecting therapies for patients with psoriasis, dermatologists need to consider that psoriasis is a life-long, systemic disease that substantially affects a patient's quality of life, according to Alan Menter, M.D., chief of the division of dermatology at Baylor University Medical Center, Dallas.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.